Study Suggests MicroRNA Panels May Aid in Pancreatic Cancer Diagnoses from Whole Blood Samples | GenomeWeb

NEW YORK (GenomeWeb News) – A study in the latest issue of the Journal of the American Medical Association suggests that measuring the blood expression levels of particular microRNA panels may bolster the accuracy of nascent non-invasive pancreatic cancer detection schemes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.